Simultaneous Molecular and Hypoxia Imaging of Brain Tumors In Vivo Using Spectroscopic Photoacoustic Tomography

Noninvasive molecular and functional imaging in vivo is promising for detecting and monitoring various physiological conditions in animals and ultimately humans. To this end, we present a novel noninvasive technology, spectroscopic photoacoustic tomography (SPAT), which offers both strong optical absorption contrast and high ultrasonic spatial resolution. Optical contrast allows spectroscopic separation of signal contributions from multiple optical absorbers (e.g., oxyhemoglobin, deoxyhemoglobin, and a molecular contrast agent), thus enabling simultaneous molecular and functional imaging. SPAT successfully imaged with high resolution the distribution of a molecular contrast agent targeting integrin overexpressed in human U87 glioblastomas in nude mouse brains. Simultaneously, SPAT also imaged the hemoglobin oxygen saturation and the total hemoglobin concentration of the vasculature, which revealed hypoxia in tumor neovasculature. Therefore, SPAT can potentially lead to better understanding of the interrelationships between hemodynamics and specific biomarkers associated with tumor progression.

[1]  F. Jöbsis.  Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. , 1977, Science.

[2]  Lihong V. Wang,et al.  Photoacoustic imaging of lacZ gene expression in vivo. , 2007, Journal of biomedical optics.

[3]  Lihong V. Wang,et al.  In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. , 2007, International journal of oncology.

[4]  Geng Ku,et al.  Noninvasive photoacoustic angiography of animal brains in vivo with near-infrared light and an optical contrast agent. , 2004, Optics letters.

[5]  D. Fraker,et al.  An integrated approach to measuring tumor oxygen status using human melanoma xenografts as a model. , 2003, Cancer research.

[6]  Jan Laufer,et al.  In vitro measurements of absolute blood oxygen saturation using pulsed near-infrared photoacoustic spectroscopy: accuracy and resolution. , 2005, Physics in medicine and biology.

[7]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[8]  Michal Neeman,et al.  Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. , 2005, Neoplasia.

[9]  Xunbin Wei,et al.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.

[10]  Eva M. Sevick-Muraca,et al.  Near-Infrared Optical Imaging of Integrin αvβ3 in Human Tumor Xenografts , 2004 .

[11]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[12]  Gary D Luker,et al.  Molecular imaging of gene expression and protein function in vivo with PET and SPECT , 2002, Journal of magnetic resonance imaging : JMRI.

[13]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[14]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[15]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[16]  R. Blasberg.  Molecular imaging and cancer. , 2003, Molecular cancer therapeutics.

[17]  D. Cheresh,et al.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.

[18]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[19]  A. Villringer,et al.  Non-invasive optical spectroscopy and imaging of human brain function , 1997, Trends in Neurosciences.

[20]  A. Kassner,et al.  Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .

[21]  A. Giaccia,et al.  Hypoxic Stress Proteins: Survival of the Fittest. , 1996, Seminars in radiation oncology.

[22]  A. Rowan.  Guide for the Care and Use of Laboratory Animals , 1979 .

[23]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[24]  Robert A Kruger,et al.  Thermoacoustic molecular imaging of small animals. , 2003, Molecular imaging.

[25]  R. Weissleder.  Molecular imaging: exploring the next frontier. , 1999, Radiology.

[26]  Geng Ku,et al.  Multiple-bandwidth photoacoustic tomography. , 2004, Physics in medicine and biology.

[27]  G. J. Diebold,et al.  Generation of ultrasonic waves from a layered photoacoustic source , 1992, Nature.

[28]  M. Dewhirst,et al.  Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. , 2005, Journal of biomedical optics.

[29]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[30]  G. Fuller,et al.  An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.

[31]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[32]  R. Tsien,et al.  green fluorescent protein , 2020, Catalysis from A to Z.

[33]  Geng Ku,et al.  Deeply penetrating photoacoustic tomography in biological tissues enhanced with an optical contrast agent. , 2005, Optics letters.

[34]  Lihong V. Wang.  Ultrasound-Mediated Biophotonic Imaging: A Review of Acousto-Optical Tomography and Photo-Acoustic Tomography , 2004, Disease markers.

[35]  Lihong V. Wang,et al.  Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain , 2003, Nature Biotechnology.

[36]  Minghua Xu,et al.  Time-domain reconstruction algorithms and numerical simulations for thermoacoustic tomography in various geometries , 2003, IEEE Transactions on Biomedical Engineering.

[37]  Dario Neri,et al.  Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.

[38]  K. T. Moesta,et al.  Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography. , 2004, Physics in medicine and biology.

[39]  R Weissleder,et al.  Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.

[40]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[41]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[42]  Vicki Brower,et al.  Tumor angiogenesis—new drugs on the block , 1999, Nature Biotechnology.

[43]  Daniel J Brat,et al.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.

[44]  W. Heindel,et al.  MR and optical approaches to molecular imaging , 2005, Abdominal Imaging.